(Press-News.org) ROCHESTER, Minn. — A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients with colorectal cancer that has spread to the liver experience more severe liver damage after chemotherapy.
For patients with colorectal liver metastases, surgery offers the best chance of long-term survival. To improve outcomes, many patients receive chemotherapy before surgery. While this approach can shrink tumors to make them more operable, one potential side effect is injury to the liver. Until now, it hasn't been clear why certain patients' livers are more prone to chemotherapy-associated liver injury.
"This is the first study to clearly show that a genetic predisposition plays a significant role in how the liver tolerates chemotherapy," says Patrick Starlinger, M.D., Ph.D., a Mayo Clinic Comprehensive Cancer Center hepatobiliary and pancreas surgeon and senior author of the study published in The Lancet eBioMedicine.
In this study, the researchers reviewed 551 patients who had chemotherapy followed by surgery to remove the tumor. They looked at liver health tests to see how chemotherapy affected liver function and genetic markers that are already linked to liver disease in other settings.
They found that a specific gene variant in the PNPLA3 gene, which is known to affect fat metabolism in the liver, was strongly linked to liver injury after chemotherapy. Patients with two copies of this variant were especially vulnerable, and all of them developed signs of significant liver injury after chemotherapy.
Genetic differences help explain global variation
According to Dr. Starlinger, the PNPLA3 variant is common worldwide, but its prevalence differs by population. For example, in Japan, the mutation is present in more than 41% of the population. It's found in more than 71% among people of Peruvian descent, but fewer than 10% of people in some European populations have it.
Because the genetic variation is more common in certain groups, such as people of Asian or Latin American descent, this may help explain why previous studies in different countries have reported conflicting results about the benefits of giving chemotherapy before and/or after surgery when treating colorectal liver metastases.
Personalizing care to maximize benefit, minimize risk
The findings suggest that a blood test to check for the PNPLA3 variant, along with monitoring liver health, could help doctors identify patients at higher risk for liver damage from chemotherapy.
"These findings offer us insight into how we can adjust treatment strategies to best manage the care for patients diagnosed with colorectal liver metastases, while potentially avoiding a negative side effect of chemotherapy," says Dr. Starlinger. "Chemotherapy may still be an appropriate treatment option, and with this information, we can personalize treatment for each patient — for example, tailoring chemotherapy or allowing more time for the liver to recover before surgery."
For a complete list of authors, disclosures and funding, review the study.
###
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.
END
New study links genetic variation to chemotherapy-related liver damage in patients with colorectal cancer liver metastases
2025-09-29
ELSE PRESS RELEASES FROM THIS DATE:
Daydreaming can lead to epiphanies, greater career purpose, WashU research finds
2025-09-29
The legendary tale of the business leader who had an epiphany that fundamentally changed his or her professional journey — turning hobbies, small observations or frustrations into billion-dollar ideas — is well known. Julia Child writing her first cookbook at 50 and becoming a famous chef; Sara Blakely channeling frustration with undergarments to develop Spanx; Jeff Bezos leaving a successful Wall Street investment career to get in on the booming growth of the internet … the list goes on.
Epiphanies — sudden realizations that transform how people see ...
High pollen count: The last straw effect on suicide risk
2025-09-29
Images
Beyond the sneezing and itchy eyes, high pollen seasons are now linked to a significant increase in suicide risk.
A new University of Michigan study found a 7.4% jump in deaths, suggesting the physical discomfort of allergies may trigger a deeper, more dangerous despair, an overlooked factor in suicide prevention.
The study indicates that allergies' physiological effects, such as poor sleep and mental distress, may contribute to this increased risk.
"A small shock could have a big effect ...
Physicists tighten the net on elusive dark matter
2025-09-29
Determining the nature of dark matter, the invisible substance that makes up most of the mass in our universe, is one of the greatest puzzles in physics. New results from the world’s most sensitive dark matter detector, LUX-ZEPLIN (LZ), have narrowed down the possibilities for one of the leading dark matter candidates: weakly interacting massive particles (WIMPs).
“While we always hope to discover a new particle, it is important for particle physics that we are able to set bounds on what the dark matter might actually be,” said UC Santa Barbara experimental ...
Laboratory breakthrough recreating star formation mechanism wins prestigious John Dawson Award
2025-09-29
Groundbreaking scientific findings on how swirling matter can form stars, planets and supermassive black holes earned a team of scientists from the U.S. Department of Energy’s (DOE) Princeton Plasma Physics Laboratory (PPPL) and Princeton University the 2025 John Dawson Award for Excellence in Plasma Physics Research from the American Physical Society (APS).
The winning team includes Fatima Ebrahimi, Erik Gilson, Hantao Ji and Yin Wang, as well as Princeton University’s Jeremy ...
New one-hour, low-cost HPV test could transform cervical cancer screening in Africa and beyond
2025-09-29
A team of researchers led by Rice University, in collaboration with colleagues in Mozambique and The University of Texas MD Anderson Cancer Center, has developed a simple, affordable human papillomavirus (HPV) test that delivers results in less than an hour with no specialized laboratory required. The breakthrough could provide an option for women in low-resource settings to be screened and treated for cervical cancer in a single clinic visit, a step that global health experts say could save countless lives. The research was recently published in Nature Communications.
Cervical cancer is considered easily preventable, yet ...
Ontology 2.0 deepens LOINC®-SNOMED collaboration, speeds global lab interoperability
2025-09-29
INDIANAPOLIS, US and LONDON, UK – Regenstrief Institute and SNOMED International have released LOINC® Ontology 2.0, the next version of The LOINC Ontology: A LOINC and SNOMED CT Interoperability Solution and a significant advance in their ongoing collaboration to streamline the exchange and use of health data worldwide.
This version expands the Ontology with approximately 6,000 additional concepts, with more than 2,500 new “Orderable Grouper” concepts that provide practical, higher-level groupings for laboratory orders. By introducing this organization, ...
Cornell launches initiative to unravel the science of menopause
2025-09-29
ITHACA, N.Y. -- Two centuries ago, few women lived long enough to reach menopause. Today, it marks a major inflection point in women’s health, yet remains poorly understood. Cornell researchers aim to change that.
Drawing on cutting-edge technology and interdisciplinary expertise, researchers are launching Menopause Health Engineering, a new initiative uniting faculty from Cornell’s Ithaca campus and Weill Cornell Medicine, to uncover how menopause shapes health and disease, and to develop urgently needed treatment ...
Reform of federal drug discount program should target misaligned incentives
2025-09-29
The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily benefiting healthcare providers.
Congress created the 340B Drug Pricing Program over 30 years ago to help hospitals and clinics that serve high levels of uninsured patients purchase outpatient drugs from manufacturers at significantly discounted prices. However, the law does not require participating providers to pass on discounts to patients or dedicate program funds to safety-net care.
A new white paper from the USC Schaeffer Center for Health Policy & Economics traces how major eligibility expansions and distorted program incentives ...
Variation in US commercial health plan coverage restrictions for cell and gene therapies
2025-09-29
About The Study: For Food and Drug Administration (FDA)-approved cell and gene therapies, commercial health plans commonly imposed coverage requirements beyond FDA-approved product labeling. These restrictions were often aligned with pivotal trial criteria, suggesting that plan coverage aligns with stronger supporting evidence.
Corresponding Author: To contact the corresponding author, James D. Chambers, PhD, email james.chambers@tuftsmedicine.org.
To access the embargoed study: Visit our For The Media website at this ...
Motivational and mobile-based support improved child passenger safety behaviors, clinical trial finds
2025-09-29
Parents improved use of appropriate child car seats after remote motivational counseling and mobile-based support, according to the results from a randomized clinical trial published in JAMA Network Open. The intervention included tailored web content, periodic text messages and personalized feedback on photos parents submitted every four to six weeks showing how their child usually travels in a car.
“Parents and children might resist using the recommended car seat or booster seat, even though it’s the law, due to inconvenience or beliefs that their child is safe enough riding ...